Ben Tre Pharmaceutical JSC (HOSE:DBT)

HOSE:DBT Income Statement

Financials in millions VND. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2019	FY 2018	FY 2017
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017
Revenue	863,355	868,411	811,616	800,500	809,914	800,114
Revenue Growth (YoY)	4.19%	7.00%	1.39%	-1.16%	1.23%	37.83%
Cost of Revenue	506,058	522,309	502,000	615,255	628,852	614,223
Gross Profit	357,297	346,103	309,616	185,245	181,063	185,890
Selling, General & Admin	297,463	296,991	242,522	155,629	153,771	154,783
Operating Expenses	297,463	296,991	242,522	155,629	153,771	154,783
Operating Income	59,834	49,112	67,094	29,616	27,292	31,107
Interest Expense	-40,369	-40,113	-39,533	-15,184	-13,210	-11,178
Interest & Investment Income	6,780	3,104	3,380	8,982	4,607	6,155
Earnings From Equity Investments	-	-	1,000	5,829	5,584	6,557
Currency Exchange Gain (Loss)	2,242	1,501	193.37	-	-	-
Other Non Operating Income (Expenses)	-7,429	1,532	-2,045	592.9	2,352	2,180
EBT Excluding Unusual Items	21,058	15,136	30,090	29,836	26,625	34,822
Gain (Loss) on Sale of Investments	-	-	-9,121	-	-	-
Gain (Loss) on Sale of Assets	1,870	1,870	2,126	-	-	-
Other Unusual Items	-	3,374	-	-	-	-
Pretax Income	22,928	20,380	23,095	29,836	26,625	34,822
Income Tax Expense	7,626	8,127	5,629	5,715	5,172	6,575
Earnings From Continuing Operations	15,301	12,253	17,466	24,121	21,453	28,246
Minority Interest in Earnings	3,309	2,328	-1,271	-2,725	-1,260	490.31
Net Income	18,610	14,581	16,195	21,396	20,193	28,737
Preferred Dividends & Other Adjustments	1,095	1,095	3,230	-	-	-
Net Income to Common	17,515	13,486	12,964	21,396	20,193	28,737
Net Income Growth	10.17%	-9.97%	-24.31%	5.96%	-29.73%	21.45%
Shares Outstanding (Basic)	21	17	16	-	-	16
Shares Outstanding (Diluted)	21	17	16	-	-	16
Shares Change (YoY)	15.25%	9.97%	-	-	-	30.49%
EPS (Basic)	853.12	772.22	816.37	-	-	1785.52
EPS (Diluted)	852.94	772.00	816.00	-	-	1785.52
EPS Growth	-10.05%	-5.39%	-	-	-	-6.93%
Free Cash Flow	-65,153	-40,869	-6,956	-80,940	-21,328	42,056
Free Cash Flow Per Share	-3173.44	-2340.22	-438.04	-	-	2613.12
Gross Margin	41.38%	39.86%	38.15%	23.14%	22.36%	23.23%
Operating Margin	6.93%	5.66%	8.27%	3.70%	3.37%	3.89%
Profit Margin	2.03%	1.55%	1.60%	2.67%	2.49%	3.59%
Free Cash Flow Margin	-7.55%	-4.71%	-0.86%	-10.11%	-2.63%	5.26%
EBITDA	77,676	65,486	75,979	42,952	40,299	42,885
EBITDA Margin	9.00%	7.54%	9.36%	5.37%	4.98%	5.36%
D&A For EBITDA	17,841	16,374	8,884	13,336	13,007	11,778
EBIT	59,834	49,112	67,094	29,616	27,292	31,107
EBIT Margin	6.93%	5.66%	8.27%	3.70%	3.37%	3.89%
Effective Tax Rate	33.26%	39.88%	24.37%	19.15%	19.43%	18.88%
Revenue as Reported	863,355	868,411	811,616	800,500	809,914	800,114
Advertising Expenses	-	3,546	6,704	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.